Header cover image

Spanish (IBEX) Pharma Industry Analysis

UpdatedDec 08, 2023
DataAggregated Company Financials
  • 7D0.6%
  • 3M1.2%
  • 1Y13.4%
  • YTD14.9%

Over the last 7 days, the Pharma industry has risen 2.3%, driven by gains from Laboratorios Farmaceuticos Rovi of 1.2%. This means that the industry has gained 13% over the past year. Earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the Spanish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 08 Dec 2023€6.0b€2.6b€296.4m15.7x20.2x2.3x
Sun, 05 Nov 2023€5.5b€2.5b€276.0m13.7x19.8x2.2x
Tue, 03 Oct 2023€6.0b€2.5b€274.5m14.7x21.7x2.4x
Thu, 31 Aug 2023€5.9b€2.5b€274.5m14.8x21.7x2.4x
Sat, 29 Jul 2023€5.3b€2.4b€273.3m12.4x19.5x2.2x
Mon, 26 Jun 2023€4.8b€2.4b€284.3m11.4x17x2x
Wed, 24 May 2023€5.1b€2.4b€284.3m11.8x17.9x2.1x
Fri, 21 Apr 2023€5.0b€2.4b€301.6m17.2x16.5x2.1x
Sun, 19 Mar 2023€4.9b€2.4b€301.6m17.6x16.2x2x
Tue, 14 Feb 2023€5.1b€2.3b€275.8m30x18.4x2.2x
Thu, 12 Jan 2023€4.8b€2.3b€275.8m28.2x17.5x2.1x
Sat, 10 Dec 2022€5.0b€2.3b€275.8m29.4x18x2.1x
Mon, 07 Nov 2022€4.9b€2.3b€303.6m23.7x16.3x2.1x
Wed, 05 Oct 2022€5.6b€2.3b€306.3m23.3x18.4x2.4x
Fri, 02 Sep 2022€5.6b€2.3b€306.3m26.3x18.3x2.4x
Sun, 31 Jul 2022€6.0b€2.3b€306.2m30x19.7x2.6x
Tue, 28 Jun 2022€6.8b€2.3b€225.4m18.4x30x3x
Thu, 26 May 2022€6.6b€2.2b€200.5m21.2x32.8x3.1x
Sat, 23 Apr 2022€7.0b€2.1b€200.5m22.4x34.9x3.3x
Mon, 21 Mar 2022€7.2b€2.1b€200.5m24.6x36x3.4x
Wed, 16 Feb 2022€6.9b€2.0b€177.1m33.4x39.1x3.4x
Fri, 14 Jan 2022€6.9b€2.0b€177.1m32.8x38.9x3.4x
Sun, 12 Dec 2021€6.9b€2.0b€177.1m33x39.1x3.4x
Tue, 09 Nov 2021€6.9b€2.0b€157.7m40.1x43.4x3.5x
Thu, 07 Oct 2021€6.8b€2.0b€151.3m37.2x44.8x3.5x
Sat, 04 Sep 2021€7.2b€2.0b€151.3m39.1x47.7x3.7x
Mon, 02 Aug 2021€7.2b€2.0b€151.3m41.2x47.6x3.7x
Thu, 06 May 2021€6.4b€1.9b€205.9m39.8x31.3x3.5x
Sun, 07 Feb 2021€5.7b€1.9b€213.8m31.9x26.6x3x
Price to Earnings Ratio


Total Market Cap: €5.4bTotal Earnings: €213.8mTotal Revenue: €1.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Spanish Pharma Industry Price to Earnings3Y Average 28.1x20222023
Current Industry PE
  • Investors are pessimistic on the Spanish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 20.3x which is lower than its 3-year average PE of 28.1x.
  • The 3-year average PS ratio of 2.8x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 12% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Spanish Healthcare industry?

ES Market0.75%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROVI Laboratorios Farmaceuticos Rovi€57.000.5%
FAE Faes Farma€3.211.1%
ALM Almirall€8.580.5%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.